Esperion Presents CLEAR Outcomes Analysis of Inflammation as Predictor of Cardiovascular Risk at American Heart Association Scientific Sessions 2023

– A Prespecified, Exploratory Analysis of Participants Reports Those with Higher Baseline Inflammation More Likely to Experience a Major Cardiovascular Event , Cardiovascular Death, and All-Cause...

Related Keywords

United States ,American ,Joanne Foody ,Tiffany Aldrich ,Alexis Callahan ,Paul Ridker ,Esperion Therapeutics Inc ,American Heart Association ,Harvard Medical School ,Exchange Commission ,Exploratory Analysis ,Participants Reports Those ,Higher Baseline Inflammation More Likely ,Major Cardiovascular Event ,Cardiovascular Death ,All Cause Mortality Compared ,Lowest Inflammation ,Patients Taking Bempedoic Acid ,Results Simultaneously Published ,Heart Association ,Chief Medical Officer ,Cardiovascular Events ,Risk Reduction ,Bempedoic Acid Among Statin Intolerant Patients ,Esperion Therapeutics ,Adverse Event ,Contact Information ,Markets ,